These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11689472

  • 1. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice.
    Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu FT, Di Mario U.
    FASEB J; 2001 Nov; 15(13):2471-9. PubMed ID: 11689472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.
    Iacobini C, Oddi G, Menini S, Amadio L, Ricci C, Di Pippo C, Sorcini M, Pricci F, Pugliese F, Pugliese G.
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F611-21. PubMed ID: 15870382
    [Abstract] [Full Text] [Related]

  • 4. Role of galectin-3 in diabetic nephropathy.
    Iacobini C, Amadio L, Oddi G, Ricci C, Barsotti P, Missori S, Sorcini M, Di Mario U, Pricci F, Pugliese G.
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S264-70. PubMed ID: 12874444
    [Abstract] [Full Text] [Related]

  • 5. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
    Pugliese G, Pricci F, Pesce C, Romeo G, Lenti E, Caltabiano V, Vetri M, Purrello F, Di Mario U.
    Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
    [Abstract] [Full Text] [Related]

  • 6. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
    Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.
    J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress.
    Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, Pugliese G.
    Diabetes; 2006 Jun; 55(6):1642-50. PubMed ID: 16731826
    [Abstract] [Full Text] [Related]

  • 9. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.
    Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
    [Abstract] [Full Text] [Related]

  • 10. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

  • 11. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.
    Pugliese G, Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Lenti L, Sale P, Gradini R, Liu FT, Di Mario U.
    Diabetes; 2000 Jul; 49(7):1249-57. PubMed ID: 10909985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.
    He CJ, Zheng F, Stitt A, Striker L, Hattori M, Vlassara H.
    Kidney Int; 2000 Nov; 58(5):1931-40. PubMed ID: 11044213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
    Liu YW, Zhu X, Zhang L, Lu Q, Wang JY, Zhang F, Guo H, Yin JL, Yin XX.
    Eur J Pharmacol; 2013 Dec 05; 721(1-3):355-64. PubMed ID: 24036348
    [Abstract] [Full Text] [Related]

  • 18. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.
    Lee SH, Kim YS, Lee SJ, Lee BC.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1409-14. PubMed ID: 21856399
    [Abstract] [Full Text] [Related]

  • 19. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
    Sourris KC, Morley AL, Koitka A, Samuel P, Coughlan MT, Penfold SA, Thomas MC, Bierhaus A, Nawroth PP, Yamamoto H, Allen TJ, Walther T, Hussain T, Cooper ME, Forbes JM.
    Diabetologia; 2010 Nov 11; 53(11):2442-51. PubMed ID: 20631980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.